Cell penetrating peptides expand pivotal roles in oncology, neurology, and immunotherapy, connecting specialized carriers ...

New insights into fibrolamellar hepatocellular carcinoma could lead to new drugs and significantly improved health outcomes.

Frizzled (FZD) proteins are the principal receptors of the Wnt signaling pathway. However, whether Wnt ligands induce FZD endocytosis and degradation remains elusive. The transmembrane E3 ubiquitin ...

Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, and young adults.

In other local dining news, a new Asian-fusion street food concept opened its first brick-and-mortar in Reading Terminal and ...

Ocugen, Inc. (NASDAQ: OCGN) this week announced the dosing of the first patient in its Phase 1 clinical trial for OCU200, a ...

Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few—in ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

Histological section of an FLC tumor, showing the stromal (left), normal (center), and tumor (right) cells. The colors correspond to gene markers ...

US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

Researchers have developed an innovative immunotoxin (a fusion protein called GrB-Fc-KS49) designed to target epithelial membrane protein-2 (EMP2), a biomarker overexpressed in more than 75% of breast ...

Researchers from China have developed a dual-reactor system that efficiently produces high-quality protein from CO2.